China Molybdenum (China) Performance
| 603993 Stock | 7.27 0.05 0.68% |
The firm shows a Beta (market volatility) of -0.0196, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning China Molybdenum are expected to decrease at a much lower rate. During the bear market, China Molybdenum is likely to outperform the market. At this point, China Molybdenum has a negative expected return of -0.0017%. Please make sure to confirm China Molybdenum's downside deviation, information ratio, and the relationship between the semi deviation and coefficient of variation , to decide if China Molybdenum performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days China Molybdenum Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, China Molybdenum is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Payout Ratio 0.2351 | Last Split Factor 30:10 | Ex Dividend Date 2024-07-08 | Last Split Date 2015-11-13 |
1 | China Molybdenum Reports Strong Q3 Financial Performance - TipRanks | 11/22/2024 |
| Begin Period Cash Flow | 29 B |
China |
China Molybdenum Relative Risk vs. Return Landscape
If you would invest 743.00 in China Molybdenum Co on August 28, 2024 and sell it today you would lose (16.00) from holding China Molybdenum Co or give up 2.15% of portfolio value over 90 days. China Molybdenum Co is generating negative expected returns and assumes 2.7212% volatility on return distribution over the 90 days horizon. Simply put, 24% of stocks are less volatile than China, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
China Molybdenum Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China Molybdenum's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as China Molybdenum Co, and traders can use it to determine the average amount a China Molybdenum's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -6.0E-4
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 603993 |
Estimated Market Risk
| 2.72 actual daily | 24 76% of assets are more volatile |
Expected Return
| 0.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average China Molybdenum is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Molybdenum by adding China Molybdenum to a well-diversified portfolio.
China Molybdenum Fundamentals Growth
China Stock prices reflect investors' perceptions of the future prospects and financial health of China Molybdenum, and China Molybdenum fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Stock performance.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.0992 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 154.54 B | ||||
| Shares Outstanding | 17.67 B | ||||
| Price To Book | 2.55 X | ||||
| Price To Sales | 0.71 X | ||||
| Revenue | 186.27 B | ||||
| Gross Profit | 16.06 B | ||||
| EBITDA | 30.53 B | ||||
| Net Income | 8.25 B | ||||
| Total Debt | 29.7 B | ||||
| Book Value Per Share | 2.95 X | ||||
| Cash Flow From Operations | 15.54 B | ||||
| Earnings Per Share | 0.66 X | ||||
| Total Asset | 172.97 B | ||||
| Retained Earnings | 23.98 B | ||||
About China Molybdenum Performance
By analyzing China Molybdenum's fundamental ratios, stakeholders can gain valuable insights into China Molybdenum's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China Molybdenum has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China Molybdenum has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
China Molybdenum is entity of China. It is traded as Stock on SHG exchange.Things to note about China Molybdenum performance evaluation
Checking the ongoing alerts about China Molybdenum for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for China Molybdenum help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China Molybdenum generated a negative expected return over the last 90 days | |
| China Molybdenum is unlikely to experience financial distress in the next 2 years | |
| About 32.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: China Molybdenum Reports Strong Q3 Financial Performance - TipRanks |
- Analyzing China Molybdenum's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China Molybdenum's stock is overvalued or undervalued compared to its peers.
- Examining China Molybdenum's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China Molybdenum's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China Molybdenum's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China Molybdenum's stock. These opinions can provide insight into China Molybdenum's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Stock analysis
When running China Molybdenum's price analysis, check to measure China Molybdenum's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Molybdenum is operating at the current time. Most of China Molybdenum's value examination focuses on studying past and present price action to predict the probability of China Molybdenum's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Molybdenum's price. Additionally, you may evaluate how the addition of China Molybdenum to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |